Esperion Therapeutics (NasdaqGM:ESPR) Update / Briefing November 11, 2025 02:00 PM ET Speaker2Good day, everyone. My name is Leila, and I will be your conference operator today. At this time, I would like to welcome you to Esperion's key opinion leader-investor event, Breaking the Statin Intolerance Barrier: Closing the Care Gap in Cardiovascular Health. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would ...